43 results on '"Kaushal, Himanshu"'
Search Results
2. 'Bane or Boon' for male epileptics: Effects of anti-seizure medications (ASMs) on semen characteristics
3. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
4. Cellular Immune Responses Against γ-Inactivated Antigen in the Recovered Cases of Kyasanur Forest Disease
5. Revisiting the tubercular zone: A poor prognostic finding on neuroimaging
6. An atypical case of hypomagnesemia-induced cerebellar syndrome with literature review
7. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
8. A case of early intraventricular haemorrhage following ventriculoperitoneal shunt: An entity requiring consideration.
9. Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants
10. Containing Post Kala-Azar Dermal Leishmaniasis (PKDL): Pre-requisite for Sustainable Elimination of Visceral Leishmaniasis (VL) from South Asia
11. Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata
12. Central Nervous System (CNS) Manifestations In Patients With Human Immunodeficiency Virus And Hepatitis C Virus Co-Infection: A Case Series with Review of Literature.
13. Needle‐free injection system delivery of ZyCoV‐D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS‐CoV‐2
14. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021
15. Host immune responses in aged rhesus macaques against BBV152, an inactivated SARSCoV-2 vaccine, and crossneutralization with beta and delta variants.
16. Chlorambucil induced papilledema: a serious yet reversible side effect of chemotherapy
17. Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
18. TNFA and IL10 Polymorphisms and IL-6 and IL-10 Levels Influence Disease Severity in Influenza A(H1N1)pdm09 Virus Infected Patients
19. Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin
20. Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial
21. Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019
22. Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime
23. Impact of the 2019 Coronavirus Infectious Disease (COVID-19) pandemic on onset to door time and admissions of new onset acute ischemic stroke in a tertiary care level hospital in North India.
24. Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
25. HOW DOES ISO 14001:2015 STANDARD IMPACT OF LIFE CYCLE PERSPECTIVE TOWARD ORGANIZATION
26. Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques
27. Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India
28. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
29. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
30. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
31. Japanese Encephalitis: A Brief Review on Indian Perspectives
32. Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis
33. Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study
34. Role of CD8+ T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
35. In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
36. Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica
37. A Patient Presenting with Diffuse Cutaneous Leishmaniasis (DCL) as a First Indicator of HIV Infection in India
38. Heat, Oriental sore, and HIV
39. In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis.
40. Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica.
41. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
42. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
43. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.